Please use this identifier to cite or link to this item: https://doi.org/10.1007/978-3-540-92841-6_366
Title: Composite PLDLLA/TCP Scaffolds for Bone Engineering: Mechanical and In Vitro Evaluations
Authors: Lam, C.X.F. 
Olkowski, R.
Swieszkowski, W.
Tan, K.C.
Gibson, I. 
Hutmacher, D.W. 
Keywords: bioresorbable scaffolds
bone
Composite
PLDLLA
tissue engineering
Issue Date: 2009
Source: Lam, C.X.F.,Olkowski, R.,Swieszkowski, W.,Tan, K.C.,Gibson, I.,Hutmacher, D.W. (2009). Composite PLDLLA/TCP Scaffolds for Bone Engineering: Mechanical and In Vitro Evaluations. IFMBE Proceedings 23 : 1480-1483. ScholarBank@NUS Repository. https://doi.org/10.1007/978-3-540-92841-6_366
Abstract: Bone tissue engineering scaffolds have two challenging functional tasks to play; to be bioactive by encouraging cell proliferation and differentiation, and to provide suitable mechanical stability upon implantation. Composites of biopolymers and bioceramics unite the advantages of both materials resulting in better processibility, enhanced mechanical properties through matrix reinforcement and osteoinductivity. Novel composite blends of poly(L-lactide-co-D,L-lactide)/tricalcium phosphate (PLDLLA/TCP) were fabricated into scaffolds by an extrusion deposition technique customised from standard rapid prototyping technology. PLDLLA/TCP composite material blends of various compositions were prepared and analysed for their mechanical properties. PLDLLA/TCP (10%) was optimised and fabricated into scaffolds. Compressive mechanical properties for the composite scaffolds were performed. In vitro studies were conducted using porcine bone-marrow stromal cells (BMSCs). Cell-scaffold constructs were induced using osteogenic induction factors for up to 8 weeks. Cell proliferation, viability and differentiation capabilities were assayed using phase contrast light microscopy, scanning electron microscopy, PicoGreen DNA quantification, AlamarBlue metabolic assay; FDA/PI fluorescent assay and western blot analysis for osteopontin. Microscopy observations showed BMSCs possessed high proliferative capabilities and demonstrated bridging across the pores of the scaffolds. FDA/PI staining as well as AlamarBlue assay showed high viability of BMSCs cultured on the composite scaffolds Cell numbers, based on DNA quantitation, was observed to increase continuously up to the 8th week of study. Western blot analysis showed increased osteopontin synthesis on the scaffolds compared to tissue culture plastic. Based on our results the PLDLLA/TCP scaffolds exhibit good potential and biocompatibility for bone tissue engineering applications.
Source Title: IFMBE Proceedings
URI: http://scholarbank.nus.edu.sg/handle/10635/85903
ISBN: 9783540928409
ISSN: 16800737
DOI: 10.1007/978-3-540-92841-6_366
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

1
checked on Feb 12, 2018

Page view(s)

48
checked on Feb 16, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.